In MDA-MB-231 cells exposed for 72 h, GANT 58 could start to reduce proliferation at the highest dose of 100 μM. In TDSCs isolated from SD rats under osteogenic induction, GANT 58 at 25 mM reduced ROS levels relative to vehicle after 48 h, as measured by flow cytometry. [1,2]
Literature-reported observations and conditions; not Adooq-tested protocols or general treatment recommendations.
Could Start to Reduce the Cell Proliferation of MDA-MB-231 Cells
Cell-based study · MDA-MB-231 cells [1]
MDA-MB-231 cells were exposed to treatment at 100 μM for 72 h. Treatment could start to reduce cell proliferation at this highest dose.
Literature-Reported Treatment Conditions
- Treatment concentration
- 100 μM
- Exposure duration
- 72 h
- Method
- exposing the cells
- Vehicle
- Dimethyl sulfoxide (DMSO)
Methods and source locations
Compound reported in the paper: GANT 58
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Results > 2.3. Reduced Cell Viability by Gli Inhibitors (S12, S13); 4. Materials and Methods > 4.3. Cell Viability Assay (S62); Figure 3 legend (S89, S92)
cell viability: cell viability; comparator: Dimethyl sulfoxide (DMSO) (0 μM) — 2. Results > 2.3. Reduced Cell Viability by Gli Inhibitors (S13); Figure 3 legend (S89)
Reduced Reactive Oxygen Species Under Osteogenic Induction
Cell-based study · TDSCs isolated from SD rats [2]
TDSCs isolated from SD rats received GANT 58 at 25 mM under osteogenic induction for 48 h. Flow cytometry showed reduced reactive oxygen species levels compared with the vehicle group.
Literature-Reported Treatment Conditions
- Treatment concentration
- 25 mM
- Exposure duration
- 48 h
- Method
- under osteogenic induction
- Vehicle
- DMSO
- Co-treatment
- Other interventions in this design: dexamethasone 10−8 M; vitamin C 50 μg/mL; β-glycerol phosphate 10 mM. Compound effect isolated by the comparison: vehicle group.
Methods and source locations
Compound reported in the paper: GANT 58
Literature evidence for the named compound in the stated model; no Adooq product-use or lot-performance claim.
2. Materials and Methods > 2.2. GANT58 and SAG Administration (S11, S12); 2. Materials and Methods > 2.6. Cells Culture (S33); 2. Materials and Methods > 2.9. Measurement of Intracellular ROS Levels (S45); 3. Results > 3.4. Regulation of Hh Signalling Affects Osteogenesis and Chondrogenesis of TDSCs In Vitro (S77); 3. Results > 3.5. Hh Signalling Regulates Antioxidant Pathway in Osteogenic Differentiation of TDSCs (S88); Figure 6 legend (S140)
reactive oxygen species (ROS) levels by flow cytometry: reactive oxygen species (ROS) levels by flow cytometry; comparator: An equal amount of the vehicle — 3. Results > 3.5. Hh Signalling Regulates Antioxidant Pathway in Osteogenic Differentiation of TDSCs (S88); Figure 6 legend (S140)